PHARMA NORD NORGE AS
Operating
Handel med legemidler, kosttilskudd og andre
handelsvarer.
Organization
- CEO
- MM
- Chairman of the board
- JD
Jørgen Dam1960
- Years since formation
- 31 years
- since Feb 20, 1995
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 5
Ownership
- Number of shares and share classes
- 100
- 1 share class
- Total number of shareholders
- 1
- person
Financials
- Total operating income 2025
- 56,292,433
- NOK
- Annual total result 2025
- 2,590,663
- NOK
- Total equity 2025
- 1,146,833
- NOK
Last update: Jun 23, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
MM | Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
JD 1960 | Chairman | - |
MM | Board Member | - |
EW 1954 | Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Auditor | - |
Last update: Feb 11, 2026
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 100 | 100 % |
Last update: Sep 25, 2026
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 56,292,433 | 52,990,433 | 37,903,775 | 35,517,760 | 42,361,860 |
Annual Total Result | 2,590,663 | 2,531,722 | 1,557,309 | 799,370 | 920,309 |
Total assets | 24,130,083 | 19,513,790 | 13,714,604 | 18,262,517 | 20,497,249 |
Total liabilities | 22,983,250 | 18,407,620 | 12,640,159 | 17,145,378 | 19,179,480 |
Total equity | 1,146,833 | 1,106,170 | 1,074,448 | 1,117,139 | 1,317,769 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 56,292,433 | 52,990,433 | 37,903,775 | 35,517,760 | 42,361,860 |
Total operating costs | 53,016,586 | 49,751,949 | 35,886,507 | 34,465,938 | 41,149,140 |
Operating result | 3,275,847 | 3,238,484 | 2,017,268 | 1,051,822 | 1,212,720 |
Financial income/costs | 47,099 | 9,577 | -20,808 | -24,148 | -31,752 |
Profit before tax | 3,322,946 | 3,248,061 | 1,996,460 | 1,027,674 | 1,180,968 |
Total tax & extraordinary income/cost | 732,283 | 716,339 | 439,151 | 228,304 | 260,659 |
Annual Total Result | 2,590,663 | 2,531,722 | 1,557,309 | 799,370 | 920,309 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 1,487,319 | 1,578,434 | 1,680,989 | 1,791,045 | 1,901,100 |
Total current assets | 22,642,764 | 17,935,356 | 12,033,615 | 16,471,472 | 18,596,149 |
Total assets | 24,130,083 | 19,513,790 | 13,714,604 | 18,262,517 | 20,497,249 |
Short term debt | 22,878,291 | 18,293,349 | 12,518,266 | 17,012,780 | 19,037,582 |
Long term debt | 0 | 114,271 | 121,893 | 132,598 | 141,898 |
Total liabilities | 22,983,250 | 18,407,620 | 12,640,159 | 17,145,378 | 19,179,480 |
Contributed capital | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 | 1,000,000 |
Retained earnings | 146,833 | 106,170 | 74,448 | 117,139 | 317,769 |
Total equity | 1,146,833 | 1,106,170 | 1,074,448 | 1,117,139 | 1,317,769 |
Total equity and liabilities | 24,130,083 | 19,513,790 | 13,714,607 | 18,262,517 | 20,497,249 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification